Clinical data | |
---|---|
Trade names | Cutivate |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration |
Intranasal, inhaled, topical cream or ointment |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 0.51% (Intranasal) |
Protein binding | 91% |
Metabolism | Intranasal Hepatic (CYP3A4-mediated) |
Biological half-life | 10 hours |
Excretion | Renal |
Identifiers | |
|
|
Synonyms | 6α,9α-Difluoro-11β,17α-dihydroxy-16α-methyl-21-thia-21-fluoromethylpregna-1,4-dien-3,20-dione |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H27F3O4S |
Molar mass | 444.508 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) |
Fluticasone is a synthetic glucocorticoid. Both the furoate and propanoate esters, fluticasone furoate and fluticasone propionate, are used as topical anti-inflammatories and inhaled corticosteroids.